All in 1 Natural Medicinal Herb Shilajit

by admin

Shilajit is one the important Ayurvedic compounds that rejuvenates the body. Shilajit is believe to be first discovered in Modern times by British Explorer Sir Martin Edward Stanley during 1870 -the time when India and Nepal were part of the British Empire. It contains more than 85 minerals in ionic form and the active principle fulvic acid, humic acid, hippuric acid and benzopyrones. It is used to treat diabetes and various urinary problems. When combined with other herbs it enhances its effect.

It is believed to have beneficial effects on the kidneys, urinary system and reproductive organs. It is considered as an aphrodisiac that is used in the treatment of impotency and infertility of both men and women. In Sanskrit shilajit means ‘feel like rock’ as it has the power of a rock to reverse the process of aging. The Indian and ancient Chinese literature mentioned shilajit as Amrit and Fountain of Youth. It is widely used by the Indian yogis of Himalayan region to have the stamina and body structure of a youth. The ancient medical literature described shilajit as conqueror of mountains and destroyer of weakness. It is considered as an anecdote for anxiety and stress. Its regular intake promotes the movement of various minerals like calcium, phosphorus and magnesium into the bones and tissues. The active principle in shilajit fulvic acid regenerates and prolongs the duration of essential nutrients in the cells. Fulvic acid restores electrical balance to damaged cells, neutralizes toxins and eliminates food poisoning in a short duration.

» Read more: All in 1 Natural Medicinal Herb Shilajit

The Assessment and Treatment of the Psychiatric Aspects Of the Female Reproductive Cycle – Part 1

by admin

The female reproductive cycle has many phases. These range from the premenstrual to the peri and postmenopausal phases. There are many variables, which can con­tribute to these reproductive phases creating psychiatric comorbidities.

In order to understand some of the more salient details of these influential variables, we need to review some basics. Epidemiologic studies over time and with large sample cohorts demonstrate that women are at a significantly greater risk for major depressive disorder when compared to men.

The National Comorbidity survey revealed that between the ages of 15 and 54 years the lifetime prevalence of Major Depressive Disorder is 12.7% for men and 21.3% for women. More recent studies demonstrate a two-fold greater lifetime risk of develop­ing Major Depressive Disorder in women. It has been suggested that the increased prevalence findings are likely to be associated with female-specific reproductive events i.e. Perimenstrual emergence, pregnancy, postpartum events and menopause.

The hormones estrogen and progesterone have been impli­cated to affect regions of the brain responsible for the modulation of certain moods and behaviors. Receptor sites for these hormones are located in the prefrontal cortex, thalamus, hippocampus and brain stem. Fluctuations in these steroi­dal gonadal hormones are thought to create a window of vulnerability for psychiatric comorbid states.

» Read more: The Assessment and Treatment of the Psychiatric Aspects Of the Female Reproductive Cycle – Part 1